Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus (SLE); Sjogren's Syndrome; Diffuse Scleroderma; Inflammatory Myopathy; ANCA Associated Systemic Vasculitis; Antiphospholipid Syndrome Intervention: Biological: BRL-301 Sponsors: Bioray Laboratories; Shanghai Changzheng Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials